Movens Capital is a Warsaw-based multi-stage venture capital fund investing €0.25–3M in CEE (and CEE diaspora) tech companies with global potential. Founded in 2018, it focuses on AI, fintech, climate tech, enterprise software, healthcare, and e-commerce infrastructure.
Founded —
Type Venture capital 4 Movens Fund 2 2026-01-15 2026-01-15 €43M €43 million raised after two closings, still targeting €60 million. Latest dated fundraising update found, not proof of the balance on research date. | Official [2025 summary](https://blog.movenscapital.com/2025-summary-at-movens-capital-f181367a3809), published 2026-01-15.
Movens Fund 2 SCA SICAV RAIF 2026-01-15 2026-01-15 €43M EUR43mraised aftertwoclosings; EUR60mtarget remainsnotverifiedfinalclose. EarlierfirstcloseEUR40mJune23 2025. EBRDEUR10mLPallocationnotfundsize.
Movens Fund 1 — €14M €14 million capitalization reported historically. Do not combine with Fund 2 target as verified AUM. | Official [SKY ENGINE investment rationale](https://movenscapital.com/2022/01/18/why-we-invested-in-sky-engine-ai/), published 2022-01-18.
Movens VC / Fund 1 — €14M HistoricalcapitalizationEUR14m reported2022-01-18; closingdateunknown,notcurrentAUM.
SHOW MORE
— — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – —
SHOW MORE
team@apexlogos.ai · 20 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size, status and stages
| Vehicle / metric | Finding | Evidence and date |
| --- | --- | --- |
| Movens Fund 2, 2025 launch | **€40 million first close; €60 million target**. These are distinct figures. | Institutional LP [PFR Ventures announcement](https://pfrventures.pl/artykul/pfr-ventures-inwestuje-w-movens-capital ), published 2025-06-23. |
| Fund 2, subsequent update | **€43 million raised after two closings**, still targeting €60 million. Latest dated fundraising update found, not proof of the balance on research date. | Official [2025 summary](https://blog.movenscapital.com/2025-summary-at-movens-capital-f181367a3809 ), published 2026-01-15. |
| EBRD commitment | €10 million institutional commitment; this is an LP allocation, not total fund size. Legal vehicle: Movens Fund 2 SCA SICAV RAIF; signed status. | [EBRD announcement](https://www.ebrd.com/home/news-and-events/news/2025/ebrd-invests--10-million-in-venture-capital-fund-movens-fund-2.html ), 2025, exact publication date not exposed; [project 55227](https://www.ebrd.com/home/work-with-us/projects/psd/55227.html ), disclosed/approved 2024-12-10, accessed 2026-10-06. |
| Movens VC / Fund 1 | €14 million capitalization reported historically. Do not combine with Fund 2 target as verified AUM. | Official [SKY ENGINE investment rationale](https://movenscapital.com/2022/01/18/why-we-invested-in-sky-engine-ai/ ), published 2022-01-18. |
| Current checks | €250,000–€3 million initial checks; follow-ons up to €5 million. PFR describes up to €5 million total company engagement, so confirm whether the limit is cumulative before entering a structured field. | [Official homepage](https://movenscapital.com/ ), undated, accessed 2026-10-06; PFR announcement, 2025-06-23. |
The current homepage FAQ explicitly supports **pre-seed, seed, Series A and A+**, with paying customers preferred at pre-seed. [Tech.eu](https://tech.eu/2025/06/23/movens-capital-launches-60m-fund-to-back-cee-tech-founders/ ) (2025-06-23) independently reports this range. The broad homepage “Growth” label should not be expanded into a Series B/later mandate without more evidence. PFR describes enterprise software, AI, climate tech, fintech, health, education and deep tech, and plans about 30 investments. EBRD identifies Poland as the predominant geography, with other CEE countries also eligible.
No dated final close at €60 million or newer fund was found in searches through 2026-10-06. Homepage promotion of “€60M” is insufficient to override the explicit €43 million raised / €60 million target distinction. Portfolio follow-on fundraising (€110–130 million in various dated statements) is company financing, not Movens AUM.
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| Movens Fund 1 | EUR 14000000 | Unknown |
| Movens VC / Fund 1 | EUR 14000000 | Unknown |
| Movens Fund 2 | EUR 43000000 | 2026-01-15 |
| Movens Fund 2 SCA SICAV RAIF | EUR 43000000 | 2026-01-15 | SHOW MORE
team@apexlogos.ai · 21 hours ago
Match research 2026-10-06 / GoldiMovensCapital / sha256:919723f467e57231b46c0990169cc08801cdbb6d3dba46c99503f282ac7a0246 / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
This negative result is bounded by public material reviewed, not a claim that the firm has never invested in neurotech.
## Attribution, conflicts, missing information and later Adex review
- Preserve exact ID `GoldiMovensCapital`. Snapshot's 2018 founding claim was not re-established by a legal founding record; the homepage narrates predecessor transactions in 2014 and first institutional fund in 2020. Distinguish brand formation from fund launch.
- Separate Movens Capital umbrella, Movens VC/Fund 1, Fund 2, growth equity and predecessor SPVs. The homepage identifies Packhelp, Fenige and Salad Story as Movens-branded SPV investments. Do not assume every portfolio company belongs to Fund 1/Fund 2 or attribute partners' earlier deals to the current vehicle.
- Consider documenting Fund 2's €43 million raised (2026-01-15) and €60 million target, with a dated status field; retain €14 million as historic Fund 1 capitalization. Legal documents/final close and aggregate AUM remain missing.
- Populate missing check fields only after resolving initial check versus cumulative exposure versus follow-on limit; the homepage's €0.25–5 million headline compresses these concepts.
- Add/review StethoMe, Attention Insight and AI Clearing as potentially missing portfolio records with the evidence above. Entry date is not necessarily announcement date. Do not import database-generated July 1 dates as verified dates for StethoMe.
- Snapshot contains both Vue Storefront and Alokai for a $20 million 2023 event (renaming risk), Certifier duplicates, and Gotiva twice from the same URL with inconsistent seed/pre-seed stage labels. Reconcile identities and rounds before any later update.
- Official portfolio Certifier entry Q3 2024 differs from the snapshot's 2023 financing lead. Check whether this reflects new exposure, formatting error or separate rounds; this research does not silently overwrite either date.
- Snapshot Cargofy round is $11 million. [Movens' official LinkedIn investment post](https://www.linkedin.com/posts/movenscapital_intercom-ai-agents-activity-7474705515273457664-vbvv ) (undated fetched text, accessed 2026-10-06) instead describes **$6 million Series A**. This may reflect primary versus secondary financing; obtain the full company release before revising the round.
- Individual Movens checks, ownership, neurotech deal history and precise allocation to each vehicle remain undisclosed/unverified. Signal adds identity/location only. All external sources were accessed 2026-10-06; publication dates are stated where exposed. No Patch, database write or commit performed. SHOW MORE
team@apexlogos.ai · 21 hours ago
Match research 2026-10-06 / GoldiMovensCapital / sha256:919723f467e57231b46c0990169cc08801cdbb6d3dba46c99503f282ac7a0246 / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# Movens Capital
- Exact Adex ID: `GoldiMovensCapital`
- Adex URL: https://adex.page/firms/GoldiMovensCapital
- Research date: 2026-10-06
- Status: Complete for research review; no Adex/database changes made.
## Identity and starting evidence
This record is Warsaw-based **Movens Capital**; the `Goldi` prefix is part of the existing exact ID, not the firm's public name. The saved read-only Adex snapshot, `data/research/_sources/GoldiMovensCapital.adex.json` (retrieved 2026-10-06), describes a CEE/diaspora generalist investing €0.25–3 million, founded in 2018. It contains 22 participation records, including SKY ENGINE AI, Doctor.one, Trusted Twin and duplicated company/round leads. Its investor check fields are null despite the range in the description. Snapshot sources include the official site, NFX Signal, Goldi and reporting; these are starting claims, not independent verification.
[NFX Signal](https://signal.nfx.com/firms/movens-capital ) was directly opened on 2026-10-06. The readable profile identifies Movens Capital and Warsaw, Poland; its team section is empty in the fetched text, with no visible fund size, stages or investment detail. This is partial access, not evidence of an empty team or portfolio.
Movens is a credible candidate for CEE AI and applied deep-tech founders, with verified synthetic-data and medical-device investments. Direct neurotechnology exposure was not verified.
## Fund size, status and stages
| Vehicle / metric | Finding | Evidence and date |
| --- | --- | --- |
| Movens Fund 2, 2025 launch | **€40 million first close; €60 million target**. These are distinct figures. | Institutional LP [PFR Ventures announcement](https://pfrventures.pl/artykul/pfr-ventures-inwestuje-w-movens-capital ), published 2025-06-23. |
| Fund 2, subsequent update | **€43 million raised after two closings**, still targeting €60 million. Latest dated fundraising update found, not proof of the balance on research date. | Official [2025 summary](https://blog.movenscapital.com/2025-summary-at-movens-capital-f181367a3809 ), published 2026-01-15. |
| EBRD commitment | €10 million institutional commitment; this is an LP allocation, not total fund size. Legal vehicle: Movens Fund 2 SCA SICAV RAIF; signed status. | [EBRD announcement](https://www.ebrd.com/home/news-and-events/news/2025/ebrd-invests--10-million-in-venture-capital-fund-movens-fund-2.html ), 2025, exact publication date not exposed; [project 55227](https://www.ebrd.com/home/work-with-us/projects/psd/55227.html ), disclosed/approved 2024-12-10, accessed 2026-10-06. |
| Movens VC / Fund 1 | €14 million capitalization reported historically. Do not combine with Fund 2 target as verified AUM. | Official [SKY ENGINE investment rationale](https://movenscapital.com/2022/01/18/why-we-invested-in-sky-engine-ai/ ), published 2022-01-18. |
| Current checks | €250,000–€3 million initial checks; follow-ons up to €5 million. PFR describes up to €5 million total company engagement, so confirm whether the limit is cumulative before entering a structured field. | [Official homepage](https://movenscapital.com/ ), undated, accessed 2026-10-06; PFR announcement, 2025-06-23. |
The current homepage FAQ explicitly supports **pre-seed, seed, Series A and A+**, with paying customers preferred at pre-seed. [Tech.eu](https://tech.eu/2025/06/23/movens-capital-launches-60m-fund-to-back-cee-tech-founders/ ) (2025-06-23) independently reports this range. The broad homepage “Growth” label should not be expanded into a Series B/later mandate without more evidence. PFR describes enterprise software, AI, climate tech, fintech, health, education and deep tech, and plans about 30 investments. EBRD identifies Poland as the predominant geography, with other CEE countries also eligible.
No dated final close at €60 million or newer fund was found in searches through 2026-10-06. Homepage promotion of “€60M” is insufficient to override the explicit €43 million raised / €60 million target distinction. Portfolio follow-on fundraising (€110–130 million in various dated statements) is company financing, not Movens AUM.
## Previous deep-tech investments
| Company | Technology and classification | Firm attribution, financing and caveats |
| --- | --- | --- |
| **SKY ENGINE AI** | Strong deep-tech case: simulation, multimodal synthetic data, domain adaptation and computer-vision training for robotics, automotive and medical imaging. Artificial neural networks do not make this neurotechnology. | Official [Movens rationale](https://movenscapital.com/2022/01/18/why-we-invested-in-sky-engine-ai/ ) (2022-01-18) reports a joint **$1.2 million** investment with HTGF “in August”; context and [official portfolio](https://movenscapital.com/our-portfolio/ ) entry Q3 2021 indicate August 2021, inferred rather than explicitly dated in that sentence. Official [company announcement](https://www.skyengine.ai/blog/sky-engine-ai-raises-dollar7m-to-accelerate-vision-ai-development-for-automotive-robotics-medical-diagnosis-and-more ) (2024-01-17) verifies participation by existing investor Movens Capital in a **$7 million Series A**, led by Cogito. Both figures are whole-round/joint amounts, not Movens checks. |
| **StethoMe** | Medical hardware and signal-processing AI: electronic stethoscope plus algorithms for remote lung/heart assessment; applied medtech deep-tech, not neural measurement. | [Official Movens portfolio](https://movenscapital.com/our-portfolio/ ) gives entry Q2 2020; [StethoMe team page](https://www.stethome.com/en-gb/about-us ) displays the Movens Capital investor logo (both undated, accessed 2026-10-06). [MamStartup](https://mamstartup.pl/stethome-zwieksza-szanse-na-transformacje-telemedycyny-pozyskujac-25-mln-dolarow/ ) (2020-07-27, marked press release) verifies Movens VC joined a **$2.5 million** round with Manta Ray, TDJ Pitango and RST VFE. Announcement date Q3 differs from official entry Q2; likely different event timing, not resolved. Public round label/lead status not established by these primary-adjacent sources. |
| **Attention Insight** (portfolio label “Attention”) | Predictive visual-attention heatmaps trained on eye-tracking observations: defensible applied ML/behavioral analytics candidate, less clear deep-tech than hardware or simulation. | Official portfolio confirms firm investment, entry Q4 2020. [AIN](https://en.ain.ua/2021/01/26/vilnius-based-company-attention-insight-raises-344k/ ) (2021-01-26) reports a **$344,000 bridge investment** from Movens VC and Open Circle Capital. Entry and announcement dates differ. [Official technology page](https://attentioninsight.com/technology/ ) (undated, accessed 2026-10-06) explains prediction without live participants, using real gaze/fixation data for model training. |
| **AI Clearing** | Drone imagery, AI and geospatial/CAD integration for automated construction progress and quality measurement; applied computer-vision deep-tech candidate. | Official Movens portfolio gives **Q4 2025** entry and the 2026-01-15 official summary names AI Clearing in the track record. No round amount, stage or specific Movens vehicle verified for this entry. The [company's $14 million Series A announcement](https://www.aiclearing.com/news/ai-clearing-an-ai-driven-construction-progress-and-quality-platform-raises-a-14m-series-a-led-by-prudence ) (2023-10-02) names Prudence, FJ Labs, Tera, Inovo and Innovation Nest, **not Movens**. Do not attribute that earlier round to Movens. |
Talkie.ai, Doctor.one, sun.store, Woltair, Alokai, Certifier and ordinary marketplace/SaaS investments should not automatically inherit a deep-tech tag. Official portfolio descriptions support health voice AI, digital care, commerce and energy-service marketplaces; category relevance alone does not establish original scientific or engineering development.
## Neurotechnology
**No verified neurotech investment found in the sources checked.** Searches included the firm name with neurotech/neuroscience and inspection of its official portfolio, saved Adex investment list and Attention Insight's product explanation.
Attention Insight is a concrete adjacent investment: visual-attention prediction uses eye-tracking studies and a neuromarketing laboratory, but the marketed product generates predictions without measuring current users' brain signals. Classify as behavioral analytics/neuromarketing adjacency unless a later source verifies neural sensing or modulation. StethoMe measures respiratory/cardiac sounds; Doctor.one is digital healthcare; Mos Health is described in the official portfolio as preventive workforce wellbeing. None provides verified direct neural technology. SKY ENGINE's neural networks are computational AI, not brain interfaces. SHOW MORE
team@apexlogos.ai · 23 days ago
MATCH 
Creandum
Alokai$20M · 2023
Vue Storefront$20M · 2023
Felix Capital
Taiwania Capital
Sky Engine Ai$7M · 2024-01-17
